Search Results 1511-1520 of 17034 for monoclonal antibody

  1. A Study to Assess the Effectiveness and Safety of Rilonacept Treatment in Subjects with Recurrent Pericarditis - Mayo Clinic

    Has a history of positive or intermediate results for hepatitis B surface antigen, hepatitis B core antibody, or hepatitis C virus antibody at screening.

  2. A Study to Obtain Blood from Patients with Gammopathies - Mayo Clinic

    Any patient with monoclonal, biclonal or triclonal gammopathy. Exclusion Criteria: Patients with serious medical problems such as congestive heart failure ...

  3. A Study of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant - Mayo Clinic

    At risk for HBV reactivation is defined as hepatitis B surface antigen positive or anti-hepatitis B core antibody positive. Previous test results obtained ...

  4. Mayo Clinic Q & A - Dr. Sudhir Kushwaha & Dr Richard Daly -...

    I'm Dr. Halena Gazelka. April is Donate Life month. When it comes to organ transplantation, patients with high levels of antibodies, also called highly ...

  5. A Study to Evaluate Mutanome-directed Immunotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    Prior exposure to cancer immunotherapy including anti-cancer vaccines, any antibody ... antibodies. Other active malignancy requiring concurrent systemic ...

  6. Drug Allergy Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate a serum IgE hemp antibody immunoassay for use in the evaluation of allergies to cannabis and other hemp products.

  7. A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia - Mayo Clinic

    ... antibodies to Hepatitis B core antigen (anti-HBc) and/or antibodies to hepatitis B surface antigen (anti-HBs) must be screened using real-time polymerase ...

  8. Myeloma Referral Study (Race, Ethnicity, and Familial Etiologic Relationship, Risk Association, and Linkage Study) - Mayo Clinic

    About this study. The goal of the present study is to answer the question of whether there are clinically relevant subtypes of monoclonal gammopathy of ...

  9. An Effectiveness and Safety Study of Daratumumab in Relapsed/Resistant Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma - Mayo Clinic

    Antibody within 4 weeks. Daratumumab or other anti-CD38 therapies; Participant has a history of malignancy (other than NHL) within 5 years before the ...

  10. A Study of the Effectiveness and Safety of CTL019 in Adult Patients with Diffuse Large B-Cell Lymphoma - Mayo Clinic

    Antibody use including anti-CD20 therapy within 4 weeks prior to infusion or 5 half-lives of the respected antibody, whichever is longer; CNS disease ...